DMDaniel Morell-Garcia

Daniel Morell-Garcia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Daniel Morell-Garcia has a total of 93 co-authors. Here are the top co-authors by number of shared publications:

  • Josep Miquel Bauça

    Department of Laboratory Medicine , Hospital Universitari Son Espases , Palma , Spain

    10 shared publications
  • Antonia Barceló

    Institut d'Investigació Sanitària de les Illes Balears (IdISBa) Palma de Mallorca Spain

    7 shared publications
  • José Antonio Peña-Zarza

    Institut d'Investigació Sanitària de les Illes Balears (IdISBa) Palma de Mallorca Spain

    5 shared publications
  • Alberto Alonso-Fernández

    Institut d’Investigació Sanitària de Les Illes Balears (IdISBa), Palma de Mallorca, Spain

    4 shared publications
  • Caterina Ribot

    Institut d'Investigació Sanitària de les Illes Balears (IdISBa) Palma de Mallorca Spain

    4 shared publications
  • Javier Piérola

    Institut d'Investigació Sanitària de les Illes Balears (IdISBa) Palma de Mallorca Spain

    4 shared publications

Latest Publications

  • Open Access

    Budget Impact Analysis of the Use of Specific Biomarkers GFAP and UCH-L1 in the Management of Mild Traumatic Brain Injury in Spain

    by Francisco Moya Torrecilla, Gemma Álvarez-Corral, Eva Gutiérrez Pérez, Daniel Morell-Garcia, Juan Ortega Pérez, Beatriz Miriam Rodríguez, Leticia Sánchez Martín, Francisco Temboury Ruiz

    Objective: To evaluate the economic impact associated with the use of specific brain biomarkers glial fibrillary acid protein (GFAP) and ubiquitin C-terminal hydrolase L1 (UCH-L1) in adult patients with suspected mild traumatic brain injury (TBI) in a standard Spanish hospital setting. Methods: We used a budget impact analysis (BIA) to compare the cost of standard of care using head computed tomography (CT) to evaluate intracranial injury with a scenario incorporating specific biomarkers GFAP and UCH-L1 in an estimated population of 3500 adult patients attending the hospital emergency department with a score of 13 to 15 on the Glasgow Coma Scale (GCS). The probabilities associated with clinical procedures were obtained from a multidisciplinary group of experts from Spanish hospitals and supplemented with data from the literature. Costs were estimated using hospital tariffs from the Spanish autonomous communities and other official sources. Results: The incorporation of specific biomarkers GFAP and UCH-L1 in the management of mild TBI could generate an estimated annual savings of EUR 696,634 in a standard Spanish hospital, mainly due to reduced CT use. The average savings per patient would be EUR 199.04, and the care time would be reduced by 111 min. Sensitivity analysis, with variations of ±20% in the parameters, confirms these savings. Conclusions: This study suggests that the use of specific biomarkers GFAP and UCH-L1 in the management of mild TBI patients in Spain could reduce the average cost per patient, generating significant savings for hospitals. Future studies that incorporate data from clinical records will help validate these results.


  • Open Access

    Budget Impact Analysis of the Use of Specific Biomarkers GFAP and UCH-L1 in the Management of Mild Traumatic Brain Injury in Spain

    by Francisco Moya Torrecilla, Gemma Álvarez Corral, Eva Gutiérrez Pérez, Daniel Morell-Garcia, Juan Ortega Pérez, Beatriz Miriam Rodríguez, Leticia Sánchez Martín, Francisco Temboury Ruiz

    Objective: To evaluate the economic impact associated with the use of specific brain biomarkers glial fibrillary acid protein (GFAP) and ubiquitin C-terminal hydrolase L1 (UCH-L1) in adult patients with suspected mild traumatic brain injury (TBI) in a standard Spanish hospital setting. Methods: We used a budget impact analysis (BIA) to compare the cost of standard of care using head computed tomography (CT) to evaluate intracranial injury with a scenario incorporating specific biomarkers GFAP and UCH-L1 in an estimated population of 3,500 adult patients attending the hospital emergency department with a score of 13 to 15 on the Glasgow Coma Scale (GCS). The probabilities associated with clinical procedures were obtained from a multidisciplinary group of experts from Spanish hospitals and supplemented with data from the literature. Costs were estimated using hospital tariffs from the Spanish autonomous communities and other official sources. Results: The incorporation of specific biomarkers GFAP and UCH-L1 in the management of mild TBI could generate estimated annual savings of €696,634 in a standard Spanish hospital, mainly due to reduced CT use. The average saving per patient would be €199.04, and the care time would be reduced by 111 minutes. Sensitivity analysis, with variations of ±20% in the parameters, confirms these savings. Conclusions: This study suggests that the use of specific biomarkers GFAP and UCH-L1 in the management of mild TBI patients in Spain could reduce the average cost per patient, generating significant savings for hospitals. Future studies that incorporate data from clinical records will help validate these results.


  • T124 Hormonal biomarkers associated with in-hospital mortality in therapeutic hypothermia after cardiac arrest: A case series

    by D. Morell-Garcia, J. Rodriguez-Pilar, M. Ferreruela-Serlavos, M.A. Ballesteros-Vizoso, P. Argente Del Castillo, J.M. Bauça, B. Barceló, J. Colomina-Climent, A. Barceló

  • Open Access

    W097 Usefulness of urine biomarkers for the prediction of in-hospital mortality in the COVID-19 patients

    by D. Morell-Garcia, D. Ramos-Chavarino, J.M. Bauça, P. Argente Del Castillo, M.A. Ballesteros-Vizoso, B. García, L. Valiña, C. Gómez-Cobo, L. García De Guadiana Romualdo, I. Llompart, et al.

  • Surfactant protein D concentration in a pediatric population with suspected sleep disorder

    by Caterina Ribot, Daniel Morell‐Garcia, Javier Piérola, José Antonio Peña-Zarza, Pilar Sanchís, Jesús Muñiz, Mónica de la Peña, Alberto Alonso‐Fernández, Antonia Barceló

    OSA affects between 2-4% in children and there is a search for new biomarkers that can be useful both in the diagnosis and in the evolution of the disease. The surfactant protein D (SP-D) is a collectin that is part of the innate immune system exerting an anti-inflammatory and antimicrobial effect. Thus, the objective of this study was to evaluate the concentration of SP-D in suspect OSA pediatric population. 178 children were recruited in this prospective study. Blood samples, sleep parameters, feeding habits, anthropometric, sociodemographic and family data were collected. Specific biochemical determinations were made, and the plasmatic concentrations of SP-D were measured by ELISA. We found no statistical correlation between the SP-D concentration and the AHI from the data. Nevertheless, the changes in SP-D levels could be correlated to a large extent by the arousals that often go along with hypopneas (r = -0.258, p =0.011 unadjusted; r = -0.258, p = 0.014 adjusted by age and BMI Z-score). Intermittent hypoxia was correlated with CRP levels (r=0.547, p<0.001 unadjusted; r=0.542, p<0.001 adjusted by age and BMI Z-score). Although AHI and SP-D did not appear to correlate, a secondary analysis suggests that sleep fragmentation, which is produced by arousals, may do, and further research is needed to determine the mechanisms by which changes in SP-D occur in OSA.

  • Vitamin D as a biomarker of health in snoring children: a familial aggregation study

    by Antonia Barceló, Daniel Morell-Garcia, Caterina Ribot, Mónica De la Peña, José Antonio Peña-Zarza, Alberto Alonso-Fernández, Paloma Giménez, Javier Piérola

    Background Hypovitaminosis D is a common health problem. The purpose of this study was to investigate the inter-relationship between serum 25(OH)D levels and paternal and maternal vitamin D status in a sample of snoring children. Methods We selected 137 participants for whom serum 25(OH)D had been measured and underwent overnight polysomnography evaluation. Serum glucose, lipids, liver enzymes, parathyroid hormone, insulin, and glycated hemoglobin were also measured. Glucose and insulin levels were used to estimate insulin resistance with the homeostasis model assessment (HOMA-IR). Results Vitamin D insufficiency (z-score and seasonality, the odds ratio for risk of vitamin D insufficiency according to the vitamin D status of parents were: OR (95% CI): paternal insufficiency 15.1 (2.7–35.7), p = 0.002; maternal insufficiency 7.2 (2.4–22), p = 0.001. When children with vitamin D deficiency were analyzed separately, serum 25(OH)D concentration was found to be associated with the apnea–hypopnea index (r = −0.647, p = 0.009) and respiratory arousal index (r = −0.669, p = 0.034). Conclusions Family patterns of vitamin D could be helpful for the early identification of children at risk of metabolic and/or sleep disturbances and when considering strategies to improve vitamin D status. Impact Family patterns of vitamin D could be helpful for the early identification of snoring children at risk of metabolic and/or sleep disturbances. Significant associations were found between serum 25-hydroxyvitamin D (25(OH)D) concentrations in children and their parents. An inverse association between 25(OH)D levels and OSA severity was detected in deficient vitamin D children. Children with insufficient and deficient vitamin D status tended to have a worse metabolic profile, so strategies are needed to improve vitamin D status.


  • Polysomnographic Characteristics of Snoring Children: A Familial Study of Obstructive Sleep Apnea Syndrome

    by Daniel Morell-Garcia, José Antonio Peña-Zarza, Pilar Sanchís, Javier Piérola, Mónica de la Peña, Josep Miquel Bauça, Nuria Toledo-Pons, Paloma Giménez, Caterina Ribot, Alberto Alonso-Fernández, et al.


  • Polysomnographic Characteristics of Snoring Children: A Familial Study of Obstructive Sleep Apnea Syndrome

    by Daniel Morell-Garcia, José Antonio Peña-Zarza, Pilar Sanchís, Javier Piérola, Mónica de la Peña, Josep Miquel Bauça, Nuria Toledo-Pons, Paloma Giménez, Caterina Ribot, Alberto Alonso-Fernández, et al.


  • Open Access

    Urine biomarkers for the prediction of mortality in COVID-19 hospitalized patients

    by Daniel Morell-Garcia, David Ramos-Chavarino, Josep M. Bauça, Paula Argente del Castillo, Maria Antonieta Ballesteros-Vizoso, Luis García de Guadiana-Romualdo, Cristina Gómez-Cobo, J. Albert Pou, Rocío Amezaga-Menéndez, Alberto Alonso-Fernández, et al.

    Risk factors associated with severity and mortality attributable to COVID-19 have been reported in different cohorts, highlighting the occurrence of acute kidney injury (AKI) in 25% of them. Among other, SARS-CoV-2 targets renal tubular cells and can cause acute renal damage. The aim of the present study was to evaluate the usefulness of urinary parameters in predicting intensive care unit (ICU) admission, mortality and development of AKI in hospitalized patients with COVID-19. Retrospective observational study, in a tertiary care hospital, between March 1st and April 19th, 2020. We recruited adult patients admitted consecutively and positive for SARS-CoV-2. Urinary and serum biomarkers were correlated with clinical outcomes (AKI, ICU admission, hospital discharge and in-hospital mortality) and evaluated using a logistic regression model and ROC curves. A total of 199 COVID-19 hospitalized patients were included. In AKI, the logistic regression model with a highest area under the curve (AUC) was reached by the combination of urine blood and previous chronic kidney disease, with an AUC of 0.676 (95%CI 0.512–0.840; p = 0.023); urine specific weight, sodium and albumin in serum, with an AUC of 0.837 (95% CI 0.766–0.909; p < 0.001) for ICU admission; and age, urine blood and lactate dehydrogenase levels in serum, with an AUC of 0.923 (95%CI 0.866–0.979; p < 0.001) for mortality prediction. For hospitalized patients with COVID-19, renal involvement and early alterations of urinary and serum parameters are useful as prognostic factors of AKI, the need for ICU admission and death.


  • Open Access

    Red cell distribution width: a new tool for the severity prediction of sleep apnoea syndrome in children

    by Daniel Morell-Garcia, Núria Toledo-Pons, Pilar Sanchis, Josep Miquel Bauça, José María Sánchez, José Peña-Zarza, Paloma Giménez, Javier Pierola, Mónica de la Peña-Bravo, Alberto Alonso-Fernández, et al.

    Introduction: Red cell distribution width (RDW) is a parameter included in the complete blood count which informs about the size of the circulating red blood cell population and its distribution. In adults, an increase in RDW was shown to be associated both with obstructive sleep apnoea (OSA) and with an increase in cardiovascular mortality. The aim of this study was to determine whether RDW is a potential biomarker for screening children with moderate–severe OSA.Methods: An observational study in snoring patients was performed. All patients underwent a sleep study and were classified either as simple snorers (apnoea–hypopnoea index (AHI) −1) or as patients with OSA (mild AHI ≥1 to −1; moderate–severe AHI ≥5 events·h−1). Blood analyses (complete blood count and C-reactive protein) were performed for every individual.Results: A total of 175 individuals were recruited. The mean age was 8.3±3.6 years. Correlation studies between RDW and several sleep-related parameters showed negative significant associations with minimum oxygen saturation, and positive significant associations with oxygen desaturation index (≥3% and ≥4%), AHI and the arousal index. A predictive model for paediatric severe OSA (AHI ≥5 events·h−1) was found based on mean corpuscular haemoglobin concentration (MCHC) 13.1% values, adjusting for body mass index z-score and age (area under the curve 0.657; p=0.004). In addition, differences were found in eosinophil count and C-reactive protein concentrations among the three subgroups.Conclusions: In children, RDW stands out as a biomarker associated with the severity of OSA. The use of RDW and MCHC could be a simple but useful tool for the severity prediction of paediatric OSA in snoring patients.